TRIAL READY (Clinical Trial Readiness)

TRIAL READY (Clinical Trial Readiness)

Publication date: Apr 12, 2019

This study, being conducted under the auspice of the CReATe Consortium, will enroll patients with ALS and related disorders as well as healthy controls, with the goal of facilitating clinical validation of leading biological-fluid based biomarker candidates that may aid therapy development for patients with ALS and related disorders.

Concepts Keywords
ALS ALS related disorder
Auspice Disorders
Biomarker ALS related disorders
Biomarkers Biomarkers
Blood Medicine
Cerebrospinal Fluid Clinical medicine
Cohort Branches of biology
Dipeptide Amyotrophic lateral sclerosis
Extracellular C9orf72
Fluid Neurofilament light polypeptide
Gender Multiple sclerosis biomarkers
Genetic Genotype
Genotype
Miami
Mutation
Neurofilament
Neurological
Neurotrophin
NfL
P75
Pharmacodynamic
Phenotype
Phosphorylated
Protocol
Receptor

Semantics

Type Source Name
disease DOID ALS
gene UNIPROT IGFALS
gene UNIPROT SOD1
gene UNIPROT AICDA
disease MESH development
disease MESH diagnosis
gene UNIPROT CTSC
disease MESH Sclerosis

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *